McGill researchers are pioneering a new artificial pancreas system that provides life-changing support to people living with type 1 diabetes.
By Ashley Rabinovitch
Published on: 27 Feb 2020
Elwyn was a healthy 13 month-old toddler when she started drinking water from the bathtub. Over time, she became increasingly thirsty and demanded more and more breast milk. For her parents, this seemed like typical behaviour related to a growth spurt. One day, however, they noticed that she was abnormally weak and rushed her to the emergency department. She was diagnosed with type 1 diabetes and had already developed a life-threatening complication of the disease known as diabetic ketoacidosis.
Category:
Published on: 14 May 2019
Adolescence can be a turbulent period of life, with struggles to establish autonomy, identity issues and risk-taking behaviours. For young adults with a chronic illness such as type 1 diabetes, this transition phase also brings about other challenges as they assume an increased responsibility for their overall health. A new study from the Research Institute of the McGill University Health Centre (RI-MUHC) sheds light on gaps in transition care practice in Quebec, pointing out a lack of standardized policies across pediatric diabetes centres.
Category:
Published on: 17 Aug 2017
McGill Newsroom
Neuron cell death may be caused by overactive immune system
A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
Category:
Published on: 28 Jun 2016
